Search

everythinglearnresearchcommunity

for

Search:↓

Patients with PCOS rate their hirsutism higher than clinicians, and these self-ratings are more closely related to their quality of life and risk of depression.

5α-Reductase inhibitors may increase depression risk but not dementia or suicide.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

New medications are improving depression treatment, emphasizing accurate diagnosis and chronic care.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

Young patients using finasteride may have higher risks of anxiety, depression, and suicidal thoughts.

Treating both the mind and skin together, especially by managing stress, can greatly improve outcomes for skin disorders linked to psychological issues.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Women with PCOS have a higher chance of experiencing depression, anxiety, and sleep disorders.

Women with PCOS and higher BMI, especially those with morbid obesity, are at greater risk for depression.

Finasteride increases risk of depression, possibly suicidal thoughts, and sexual dysfunction.

Finasteride may cause lasting sexual and mental health issues, and genetic screening could help prevent them.

Most women with PCOS use positive coping strategies, but some with more psychological stress use negative ones.

Skin diseases, especially psoriasis, greatly affect people's quality of life, similar to chronic diseases.

Greater intimacy leads to better self-reported health in couples having infertility treatment.

Mindfulness reduces anxiety and depression in skin disease patients; dermatologists and psychiatrists often lack confidence in treating psychodermatological conditions.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Testosterone treatment in transgender teens can worsen acne, requiring careful treatment due to mental health and medication side effects.

The safety and effectiveness of gender-affirming treatments for children are uncertain, with potential long-term risks like infertility.

Direct-to-consumer teledermatology platforms have financial conflicts of interest and lack proper patient care and follow-up.

Hair loss significantly affects quality of life, wet combing is better than visual inspection for finding head lice, many with oral lichen planus have allergies, and wet wraps with steroids quickly improve itchy skin conditions.

Aging in hair follicle stem cells leads to hair graying, thinning, and loss.

In teens with Polycystic Ovary Syndrome and obesity, issues related to metabolism, skin, and mental health are common, and a clinic with various specialists can provide care for most of these problems.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Topical finasteride is an effective and safer treatment for male hair loss.

Shift work disrupts the body's natural clock, leading to health problems.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.